Per the applicant, taurolidine/heparin is a proprietary formulation of taurolidine, a thiadiazinane antimicrobial, and heparin, an anti-coagulant, that is under development for use as catheter lock solution, with the aim of reducing the risk of catheter-related bloodstream infections (CRBSI) from in-dwelling catheters in patients undergoing hemodialysis (HD) through a central venous catheter (CVC)
If a procedure is scheduled in advance of the encounter, the medical necessity for that procedure has already been determined and the treatment has already been decided
MTTP gene transcription is positively regulated by PPAR and increased MTTP expression is paralleled by a change in apoB100 secretion, but a paradoxical decrease in circulating triglycerides in mice [116]
Protein expression of mmp-2 and mt1-mmp in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma
Monitor duration as several benefits decrease after stopping treatment
Q.DingG.ChengZ